— Bringing Global AI Assets from Hugging Face and Beyond into Practice, Expanding Analytical Options and Accelerating DX in Research —
Tokyo, Japan — May 1, 2026 — CarbGeM Inc. (Headquarters: Shibuya-ku, Tokyo; CEO: Masakazu Nakajima; hereinafter “CarbGeM”), a company advancing digital transformation (DX) across life sciences research, development, and field operations through the integration of cutting-edge biotechnology and digital technologies, today announced the official release of “Community Applications,” a new feature on its life sciences AI platform “CarbConnect®.” The new feature enables users to instantly leverage high-value AI analytical models from around the world directly within their web browser.
Researchers worldwide publish advanced AI models through repositories such as Hugging Face. However, integrating these state-of-the-art algorithms into actual research workflows typically requires building dedicated analytical environments and significant IT expertise — creating a substantial barrier to real-world adoption.
By providing a platform that seamlessly bridges “cutting-edge knowledge” and “field-level practice,” CarbGeM is creating an environment in which every scientist can readily benefit from the latest technologies, advancing the “democratization of AI” in life sciences.
This new feature optimizes openly available AI assets from the global community and integrates them into CarbConnect® through an intuitive user interface. Users can obtain advanced inference results immediately by simply uploading their data — no environment setup or specialized engineering required.
Important Notice: These applications are provided for Research Use Only (RUO). The results generated are not intended to substitute for professional medical diagnosis or to be relied upon for clinical decision-making.
1. BiomedCLIP 1.0 — Biomedical Image Classification
Technology Overview: Built on “BioCLIP,” a vision-language foundation model developed by Microsoft and trained on millions of biological images and text pairs. The model has been adapted to output terminology relevant to the clinical laboratory domain based on the input image.
Key Benefit: Supports learning and skill-building for those new to clinical laboratory science.
2. Skin Cancer 1.0 — Image Classification
*The skin image shown is synthetic.
Technology Overview: A model that classifies seven categories of skin lesions, including benign types, from dermoscopic images.
Key Benefit: Capable of analyzing images captured with a smartphone camera, enabling simple educational checks on skin lesions of interest and supporting awareness around early detection. (For research and educational use only; not a substitute for medical diagnosis.)
Beyond its proprietary solutions, CarbConnect® aims to integrate the diverse knowledge generated by the global research community, enabling researchers to rapidly assemble the analytical environments they truly need.
Going forward, CarbGeM will continue to expand the range of supported analyses and platform capabilities, broadening the possibilities of data utilization across life sciences. As a partner supporting the digitalization of research workflows, CarbGeM remains committed to advancing scientific progress and operational efficiency.
CarbConnect® is a cloud-based AI image analysis platform provided by CarbGeM Inc. It serves as the foundation for AI model training, validation, deployment, and real-world implementation in life sciences, and is positioned as an industry-academia-government collaborative platform for translating AI research into societal impact.
Platform URL: https://www.carb-connect.com/
Community Applications List: https://www.carb-connect.com/applications
CarbGeM Inc. drives diagnostic support, research efficiency, and the standardization and automation of quality control across the life sciences sector through advanced technologies, including the development of approved Software as a Medical Device (SaMD). The company addresses pressing societal challenges such as the shortage of skilled technicians and regional disparities in healthcare, supporting medical and industrial fields by delivering accurate and timely results.
Leveraging AI technologies and digital platforms, CarbGeM provides solutions that support evidence-based decision-making across research-use AI, public sector applications, and industrial DX. The company has received numerous accolades both in Japan and abroad, including selection in the “Global Top 10” of the AI Impact Summit 2026 hosted by the Government of India in February 2026, and the “Excellence Award” in the Software Category at the 38th Outstanding Technology and Product Awards for Small and Medium Enterprises in April 2026. Through industry-academia-government collaboration and open innovation, CarbGeM is committed to co-creating the future of regional development, healthcare, and research.
CarbGeM Inc. drives diagnostic support, research efficiency, and the standardization and automation of quality control across the life sciences sector through advanced technologies, including the development of approved Software as a Medical Device (SaMD). The company addresses pressing societal challenges such as the shortage of skilled technicians and regional disparities in healthcare, supporting medical and industrial fields by delivering accurate and timely results.
Leveraging AI technologies and digital platforms, CarbGeM provides solutions that support evidence-based decision-making across research-use AI, public sector applications, and industrial DX. The company has received numerous accolades both in Japan and abroad, including selection in the “Global Top 10” of the AI Impact Summit 2026 hosted by the Government of India in February 2026, and the “Excellence Award” in the Software Category at the 38th Outstanding Technology and Product Awards for Small and Medium Enterprises in April 2026. Through industry-academia-government collaboration and open innovation, CarbGeM is committed to co-creating the future of regional development, healthcare, and research.
| Company Name | CarbGeM Inc. |
| Representative | Masakazu Nakajima, CEO |
| Headquarters | Shibuya-ku, Tokyo, Japan |
| Founded | March 2021 |
| Business | Development and provision of AI- and biotechnology-based solutions for the life sciences sector |
| Website | https://carbgem.com/en/ |
